Chargement en cours...
An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy
PURPOSE: This pilot study assessed the efficacy of 12 weeks of daily treatment with a vaginal gel based on a water-based cellulose gel in reducing the severity of moderate–severe symptoms of vulvovaginal atrophy (VVA) and followed adverse events in female breast cancer patients undergoing treatment...
Enregistré dans:
| Publié dans: | Med Devices (Auckl) |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8242146/ https://ncbi.nlm.nih.gov/pubmed/34234580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/MDER.S303234 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|